Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Meningococcal Serogroup B Vaccines Can Be Approved With Surrogate Endpoints, FDA Says

Mar 25 2011

• By The Pink Sheet Daily

Related Content

Meningococcal Vaccine Development To Get FDA Advisory Cmte. Review

Mar 11 2011

Advisory Committee Splits The Difference On CABP Trials

Dec 21 2009

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window